赛伦生物：2025年前三季度归属于上市公司股东的净利润同比增长2.01%

Core Insights - The company reported a revenue of 175,138,574.09 yuan for the first three quarters of 2025, representing a year-on-year growth of 1.07% [1] - The net profit attributable to shareholders of the listed company was 64,210,654.81 yuan, showing a year-on-year increase of 2.01% [1] Financial Performance - Revenue for the first three quarters of 2025: 175.14 million yuan [1] - Year-on-year revenue growth: 1.07% [1] - Net profit for the first three quarters of 2025: 64.21 million yuan [1] - Year-on-year net profit growth: 2.01% [1]